The RT-qPCR, western blot and immunohistochemistry (IHC) analyses confirmed that SFXN4 displayed elevated expression at both RNA and protein levels in osteosarcoma tissues and cells, whereas SQOR exhibited heightened abundance in normal tissues and cells (Figures 10A–C). The gene discussed is SFXN4; the disease is osteosarcoma.